Healthcare provider profile · identity verified

Ronald J. Correa, M.D.

Family Practice · LA HABRA, CA · NPI 1821035536

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	322	97
Metformin Hcl	Metformin Hcl	285	83
Lisinopril	Lisinopril	214	58
Losartan Potassium	Losartan Potassium	203	63
Levothyroxine Sodium	Levothyroxine Sodium	198	62
Escitalopram Oxalate	Escitalopram Oxalate	177	63
Omeprazole	Omeprazole	166	46
Simvastatin	Simvastatin	162	54
Amlodipine Besylate	Amlodipine Besylate	132	46
Furosemide	Furosemide	128	38
Lorazepam	Lorazepam	128	42
Alprazolam	Alprazolam	123	18
Gabapentin	Gabapentin	123	35
Glimepiride	Glimepiride	106	40
Albuterol Sulfate Hfa	Albuterol Sulfate	98	20
Pantoprazole Sodium	Pantoprazole Sodium	97	27
Memantine Hcl	Memantine Hcl	95	27
Doxazosin Mesylate	Doxazosin Mesylate	94	25
Donepezil Hcl	Donepezil Hcl	87	23
Tramadol Hcl	Tramadol Hcl	87	15
Alendronate Sodium	Alendronate Sodium	85	25
Eliquis	Apixaban	81	15
Glipizide	Glipizide	74	20
Finasteride	Finasteride	72	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	64	44
Metoprolol Tartrate	Metoprolol Tartrate	63	18
Atenolol	Atenolol	61	21
Doxycycline Hyclate	Doxycycline Hyclate	59	42
Montelukast Sodium	Montelukast Sodium	57	17
Ozempic	Semaglutide	57	suppressed
Carvedilol	Carvedilol	56	14
Duloxetine Hcl	Duloxetine Hcl	55	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	55	15
Hydrochlorothiazide	Hydrochlorothiazide	52	16
Tizanidine Hcl	Tizanidine Hcl	52	13
Diclofenac Sodium	Diclofenac Sodium	51	15
Clopidogrel	Clopidogrel Bisulfate	49	13
Pioglitazone Hcl	Pioglitazone Hcl	49	13
Betamethasone Dipropionate	Betamethasone Dipropionate	46	16
Famotidine	Famotidine	46	17
Allopurinol	Allopurinol	45	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Azithromycin	Azithromycin	42	30
Divalproex Sodium Er	Divalproex Sodium	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Prednisone	Prednisone	37	19
Fenofibrate	Fenofibrate,micronized	36	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	29
Ibuprofen	Ibuprofen	34	12
Valsartan	Valsartan	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	14
Metoclopramide Hcl	Metoclopramide Hcl	32	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	32	suppressed
Nystatin	Nystatin	29	11
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Metoprolol Succinate	Metoprolol Succinate	27	suppressed
Albuterol Sulfate	Albuterol Sulfate	26	suppressed
Baclofen	Baclofen	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Carbamazepine	Carbamazepine	25	suppressed
Risperidone Odt	Risperidone	25	suppressed
Sertraline Hcl	Sertraline Hcl	25	suppressed
Meloxicam	Meloxicam	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Ketoconazole	Ketoconazole	21	12
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Amoxicillin	Amoxicillin	17	15
Ezetimibe	Ezetimibe	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Naproxen	Naproxen	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Carisoprodol	Carisoprodol	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Methimazole	Methimazole	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Risperidone	Risperidone	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	14	suppressed
Budesonide	Budesonide	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Niacin Er	Niacin	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Acetylcysteine	Acetylcysteine	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Ibu	Ibuprofen	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error